Dimensional Fund Advisors LP X Biotech Inc. Transaction History

Dimensional Fund Advisors LP

$403 Billion
Q3 2024

A detailed history of Dimensional Fund Advisors LP transactions in X Biotech Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 72,475 shares of XBIT stock, worth $242,066. This represents 0.0% of its overall portfolio holdings.

Number of Shares

72,475

Previous 72,475 -0.0%

Holding current value

$242,066

Previous $372,000 50.54%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$4.02 - $5.81 $7,392 - $10,684	-1,839 Reduced 2.47%	72,475 $298,000
Q2 2023 Aug 09, 2023	SELL	$3.06 - $6.38 $2,484 - $5,180	-812 Reduced 1.08%	74,314 $441,000
Q1 2023 May 12, 2023	SELL	$3.22 - $4.72 $23,415 - $34,323	-7,272 Reduced 8.83%	75,126 $259,000
Q4 2022 Feb 09, 2023	SELL	$3.03 - $3.79 $11,741 - $14,686	-3,875 Reduced 4.49%	82,398 $289,000
Q3 2022 Nov 10, 2022	SELL	$3.58 - $5.88 $289,342 - $475,233	-80,822 Reduced 48.37%	86,273 $312,000
Q2 2022 Aug 12, 2022	BUY	$5.13 - $9.2 $67,598 - $121,228	13,177 Added 8.56%	167,095 $941,000
Q1 2022 May 13, 2022	BUY	$8.64 - $11.71 $448,174 - $607,421	51,872 Added 50.83%	153,918 $1.33 Million
Q4 2021 Feb 09, 2022	BUY	$10.95 - $16.07 $730,507 - $1.07 Million	66,713 Added 188.81%	102,046 $1.14 Million
Q3 2021 Nov 12, 2021	BUY	$12.95 - $18.24 $123,724 - $174,264	9,554 Added 37.06%	35,333 $458,000
Q2 2021 Aug 12, 2021	SELL	$15.83 - $17.84 $25,913 - $29,204	-1,637 Reduced 5.97%	25,779 $427,000
Q4 2020 Feb 25, 2021	BUY	$15.65 - $19.92 $429,060 - $546,126	27,416 New	27,416 $429,000

Others Institutions Holding XBIT

# of Institutions

Shares Held

4.9M

Call Options Held

Put Options Held

View Full List

About XBiotech Inc.

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $102M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

More about XBIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP X Biotech Inc. Transaction History